AstraZeneca (AZN)

Create an Alert
51.00 +0.03  +0.05%   NYSE Jun 18, 5:00PM BATS Real time Currency in USD

AstraZeneca Enterprise Value:

66.11B for June 18, 2013
View Full Chart

AstraZeneca Enterprise Value Chart

    AstraZeneca Historical Enterprise Value Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 93   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    June 18, 2013 66.11B
    June 17, 2013 66.09B
    June 14, 2013 65.88B
    June 13, 2013 66.21B
    June 12, 2013 66.10B
    June 11, 2013 66.05B
    June 10, 2013 66.63B
    June 7, 2013 66.69B
    June 6, 2013 66.74B
    June 5, 2013 65.88B
    June 4, 2013 66.44B
    June 3, 2013 66.74B
    May 31, 2013 66.44B
    May 30, 2013 67.58B
    May 29, 2013 67.73B
    May 28, 2013 68.64B
    May 24, 2013 67.59B
    May 23, 2013 67.48B
    May 22, 2013 67.81B
    May 21, 2013 67.01B
    May 20, 2013 66.75B
    May 17, 2013 66.83B
    May 16, 2013 67.16B
    May 15, 2013 67.06B
    May 14, 2013 66.36B
       
    May 13, 2013 66.58B
    May 10, 2013 66.80B
    May 9, 2013 66.85B
    May 8, 2013 66.96B
    May 7, 2013 66.65B
    May 6, 2013 66.90B
    May 3, 2013 67.41B
    May 2, 2013 66.66B
    May 1, 2013 66.86B
    April 30, 2013 67.28B
    April 29, 2013 67.59B
    April 26, 2013 66.81B
    April 25, 2013 66.28B
    April 24, 2013 66.69B
    April 23, 2013 67.30B
    April 22, 2013 66.49B
    April 19, 2013 66.40B
    April 18, 2013 66.20B
    April 17, 2013 65.88B
    April 16, 2013 66.28B
    April 15, 2013 65.96B
    April 12, 2013 66.53B
    April 11, 2013 66.34B
    April 10, 2013 66.13B
    April 9, 2013 65.60B

    About Enterprise Value

    Click "Learn More" below to see how YCharts calculates Enterprise Value.

    Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

    EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
    Learn More

    Get data for

    AZN Enterprise Value Benchmarks

    Companies
    GlaxoSmithKline 153.47B
    Pfizer 211.90B
    Merck 151.84B

    AZN Enterprise Value Rankings

    Overall 98th percentile
    172 of 16770
    Sector 98th percentile
    18 of 1408 in Healthcare
    Industry 91st percentile
    11 of 135 in Drug Manufacturers - Major

    AZN Enterprise Value Range, Past 5 Years

    Minimum 40.64B Mar 9 2009
    Maximum 82.91B Aug 5 2008
    Average 64.30B

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');